3.0.0 1698 2023-01-13T04:50:01Z 2023-01-13T04:50:01Z Senate S S 2005-09-14 109 ssfi00 Finance Committee Senate Standing Referred to 2005-09-14T19:44:37Z Vaccines for the New Millennium Act of 2005 109 3781 HR 2005-10-17 Referred to the Subcommittee on Domestic and International Monetary Policy, Trade, and Technology. Identical bill CRS 2005-09-14 ssfi00 Finance Committee Senate Read twice and referred to the Committee on Finance. (text of measure as introduced: CR S10040-10043) IntroReferral 2005-09-14 Sponsor introductory remarks on measure. (CR S10039-10040) IntroReferral B00100 9 Library of Congress 2005-09-14 Introduced in Senate IntroReferral 10000 9 Library of Congress K000148 Sen. Kerry, John F. [D-MA] JOHN KERRY D MA FORBES N L000504 Sen. Lugar, Richard G. [R-IN] RICHARD LUGAR R IN GREEN 2005-09-14 True B000444 Sen. Biden, Joseph R., Jr. [D-DE] JOSEPH BIDEN D DE ROBINETTE 2005-10-17 False D000563 Sen. Durbin, Richard J. [D-IL] Richard Durbin D IL J. 2005-12-12 False S001163 Sen. Salazar, Ken [D-CO] Ken Salazar D CO 2006-02-02 False M001111 Sen. Murray, Patty [D-WA] Patty Murray D WA 2006-05-09 False C000127 Sen. Cantwell, Maria [D-WA] Maria Cantwell D WA 2006-05-12 False Health AIDS (Disease) Child health Clinical trials Commerce Communicable diseases Competition Congress Congressional reporting requirements Contracts Corporation taxes Developing countries Development credit institutions Dispute settlement Drug approvals Drug industry Drugs Economics and Public Finance Families Foreign Trade and International Finance Gifts Government Operations and Politics Government contractors Government procurement Government trust funds Governmental investigations Human immunodeficiency viruses Income tax Intellectual property International Affairs International agencies International cooperation in science Law Liability (Law) Malaria Medical malpractice Medical technology Negotiations Nongovernmental organizations Nonprofit organizations Patents Pharmaceutical research Preventive medicine Prices Public-private partnerships Research and development Research and development tax credit Research grants Science, Technology, Communications Small business Social Welfare Tax credits Tax refunds Taxation Technology transfer Treaties Tuberculosis United Nations Vaccination Vaccines World health Health 00 2005-09-14 Introduced in Senate 2005-11-08T20:07:31Z Vaccines for the New Millennium Act of 2005 - Directs the President to establish a strategy to accelerate efforts to develop vaccines and microbicides for neglected diseases such as HIV/AIDS, malaria, and tuberculosis, which shall: (1) expand public-private partnerships; (2) create economic incentives for such vaccines' research, development, and manufacturing; (3) include the negotiation of advanced market commitments; (4) address related intellectual property and regulatory approval issues; (5) maximize U.S. capabilities to support clinical trials in developing countries; (6) expand the purchase and delivery of existing vaccines; and (7) address the challenges of advance delivery of vaccines in developing countries.

Directs the Secretary of the Treasury to: (1) enter into negotiations with the World Bank, the International Development Association, Global Alliance for Vaccines and Immunizations, and other interested parties to establish advanced market commitments to purchase such vaccines and microbicides; and (2) establish in the Treasury the Lifesaving Vaccine Purchase Fund.

Amends the Internal Revenue Code to establish business credits for: (1) vaccine research related to HIV/AIDS, malaria, tuberculosis, or certain infectious diseases afflicting developing countries; and (2) certain sales of lifesaving vaccines to nonprofit organizations, or to foreign governments or instrumentalities for distribution in developing countries.

Amends the Small Business Act to: (1) direct the Small Business Administration (SBA) to establish a four-year pilot program to encourage the development of such vaccines and microbicides, including program outreach activities; and (2) provide Small Business Innovation Research Program (SBIR) and Small Business Technology Transfer Program (STTR) funding for such vaccines and microbicides.

]]> Vaccines for the New Millennium Act of 2005 Display Title Vaccines for the New Millennium Act of 2005 Official Title as Introduced A bill to accelerate efforts to develop vaccines for diseases primarily affecting developing countries, and for other purposes. Introduced in Senate IS Short Titles as Introduced Vaccines for the New Millennium Act of 2005 Introduced in Senate 2005-09-14T04:00:00Z https://www.govinfo.gov/content/pkg/BILLS-109s1698is/xml/BILLS-109s1698is.xml 2005-09-14 Read twice and referred to the Committee on Finance. (text of measure as introduced: CR S10040-10043) text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. Congressional Research Service, Library of Congress This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.